OmniAb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OmniAb and other ETFs, options, and stocks.

About OABI

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. 

CEO
Matthew William Foehr
CEOMatthew William Foehr
Employees
114
Employees114
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
2015
Founded2015
Employees
114
Employees114

OABI Key Statistics

Market cap
220.20M
Market cap220.20M
Price-Earnings ratio
-2.89
Price-Earnings ratio-2.89
Dividend yield
Dividend yield
Average volume
1.58M
Average volume1.58M
High today
$1.82
High today$1.82
Low today
$1.64
Low today$1.64
Open price
$1.67
Open price$1.67
Volume
867.83K
Volume867.83K
52 Week high
$4.96
52 Week high$4.96
52 Week low
$1.22
52 Week low$1.22

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own OABI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.